Cheng et al. reported that miR-199a suppresses the tumorigenicity and chemoresistance of ovarian CSCs/TICs (CD44+CD117+ population) enriched from human primary ovarian tumor tissues [78]. Here, CD44 is linked to ovarian neoplasm.